Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.13MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 0 | $ -1.13M | $ -1.13M |
| 3/31/2025 | $ 0 | $ 30.66M | $ 30.66M |
| 12/31/2024 | $ 0 | $ 20.25M | $ 20.25M |
| 9/30/2024 | $ 0 | $ 22.68M | $ 22.68M |
| 6/30/2024 | $ 0 | $ 26.94M | $ 26.94M |
| 3/31/2024 | $ 0 | $ 333.76K | $ 333.76K |
| 12/31/2023 | $ 0 | $ -1.14M | $ -1.14M |
| 9/30/2023 | $ 0 | $ -1.28M | $ -1.28M |
| 6/30/2023 | $ 0 | $ -5.95M | $ -5.95M |
| 3/31/2023 | $ 0 | $ -4.32M | $ -4.32M |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) EBITDA stands at $ -3.46M.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average EBITDA has been $ 2.26M.
- The median EBITDA for PHARMACYTE BIOTECH INC during this period was $ -3.5M
- PHARMACYTE BIOTECH INC reached its highest EBITDA over the past 5 years at $ 30.66M.
- The lowest EBITDA recorded by PHARMACYTE BIOTECH INC in the same timeframe $ -5.95M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for PHARMACYTE BIOTECH INC is calculated as follows: EBIT [ $ -3.46M ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -3.46M ] PMCB - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -5.95M
Minimum
Jun 30, 2023
$ 30.66M
Maximum
Mar 31, 2025
$ 2.26M
Average
$ -3.5M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.24K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.9M |
| median | $ 8.92M |
| std | $ 167.01M |